Puma Biotechnology Reports Second Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 9.67 +0.16 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.51 | 52 Week High | $82.81 | |||
| Open | $9.45 | 52 Week Low | $19.74 | |||
| Day High | $9.78 | P/E | N/A | |||
| Day Low | $9.33 | EPS | $-2.16 | |||
| Volume | 297,628 | |||||
